Reig-López, J.; Maldonado, M.d.M.; Merino-Sanjuan, M.; Cruz-Collazo, A.M.; Ruiz-Calderón, J.F.; Mangas-Sanjuán, V.; Dharmawardhane, S.; Duconge, J.
Physiologically-Based Pharmacokinetic/Pharmacodynamic Model of MBQ-167 to Predict Tumor Growth Inhibition in Mice. Pharmaceutics 2020, 12, 975.
https://doi.org/10.3390/pharmaceutics12100975
AMA Style
Reig-López J, Maldonado MdM, Merino-Sanjuan M, Cruz-Collazo AM, Ruiz-Calderón JF, Mangas-Sanjuán V, Dharmawardhane S, Duconge J.
Physiologically-Based Pharmacokinetic/Pharmacodynamic Model of MBQ-167 to Predict Tumor Growth Inhibition in Mice. Pharmaceutics. 2020; 12(10):975.
https://doi.org/10.3390/pharmaceutics12100975
Chicago/Turabian Style
Reig-López, Javier, MarÃa del Mar Maldonado, Matilde Merino-Sanjuan, Ailed M. Cruz-Collazo, Jean F. Ruiz-Calderón, Victor Mangas-Sanjuán, Suranganie Dharmawardhane, and Jorge Duconge.
2020. "Physiologically-Based Pharmacokinetic/Pharmacodynamic Model of MBQ-167 to Predict Tumor Growth Inhibition in Mice" Pharmaceutics 12, no. 10: 975.
https://doi.org/10.3390/pharmaceutics12100975
APA Style
Reig-López, J., Maldonado, M. d. M., Merino-Sanjuan, M., Cruz-Collazo, A. M., Ruiz-Calderón, J. F., Mangas-Sanjuán, V., Dharmawardhane, S., & Duconge, J.
(2020). Physiologically-Based Pharmacokinetic/Pharmacodynamic Model of MBQ-167 to Predict Tumor Growth Inhibition in Mice. Pharmaceutics, 12(10), 975.
https://doi.org/10.3390/pharmaceutics12100975